Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2000
09/19/2000US6120856 Coated, resuspendable magnetically responsive, transition metal oxide particles and method for the preparation thereof
09/19/2000US6120794 Emulsion and micellar formulations for the delivery of biologically active substances to cells
09/19/2000US6120777 High fluorescence specific immune enhancing factor and methods of use for same
09/19/2000US6120776 Kit containing vaccine and diagnostic test
09/19/2000US6120775 Administering a vaccine containing attenuated bacterium
09/19/2000US6120774 Heterophil-adapted poultry vaccine
09/19/2000US6120773 Recombinant herpes simplex viruses vaccines and methods
09/19/2000US6120771 Isolated polypeptide; diagnosis, therapy
09/19/2000US6120770 Isolated polypeptide
09/19/2000US6120767 Genetic engineering
09/19/2000US6120766 CDW52-specific antibody for treatment of multiple sclerosis
09/19/2000US6120763 Compositions and methods for enhanced tumor cell immunity in vivo
09/19/2000CA2065365C Bovine coronavirus polypeptides and vaccines
09/14/2000WO2000053800A1 METHOD TO SEARCH FOR MALE ANTIFERTILITY DRUGS BASED ON PHGPx ACTIVITY DETERMINATION
09/14/2000WO2000053787A1 Prrsv vaccines
09/14/2000WO2000053786A1 Stable recombinant influenza viruses free of helper viruses
09/14/2000WO2000053774A2 Metalloproteinases and methods of use therefor
09/14/2000WO2000053767A2 Nucleic acid respiratory syncytial virus vaccines
09/14/2000WO2000053766A1 Non-spreading pestivirus
09/14/2000WO2000053765A1 Cloning and expression of haemophilus somnus transferrin-binding proteins
09/14/2000WO2000053764A1 Chlamydia antigens and corresponding dna fragments and uses thereof
09/14/2000WO2000053750A1 Compositions and methods for the treatment of tumors
09/14/2000WO2000053748A2 Casb618 polynucleotides and polypeptides and their use
09/14/2000WO2000053742A2 Polynucleotides and proteins encoded thereby
09/14/2000WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
09/14/2000WO2000053628A2 Genes encoding human potassium channel proteins
09/14/2000WO2000053229A2 Protein conjugates on the basis of lumazine synthase, methods for producing them and the use thereof
09/14/2000WO2000053223A1 Apoptosis inducing molecule ii and methods of use
09/14/2000WO2000053222A1 Enhancing immune response in animals
09/14/2000WO2000053221A1 Intranasal delivery of pneumococcal polysaccharide vaccines
09/14/2000WO2000053220A1 Lipoglycan compositions and methods of treating parasitic infections
09/14/2000WO2000053219A2 Compositions and methods for treating cancer and hyperproliferative disorders
09/14/2000WO2000053218A1 Neurodegenerative disorder related gene
09/14/2000WO2000053216A2 Use of casb616 polypeptides and polynucleotides for cancer treatment
09/14/2000WO2000053215A2 Deglycosylated ricin toxin a-chain vaccine
09/14/2000WO2000053209A1 Treatment of autoimmune disease
09/14/2000WO2000053168A2 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders
09/14/2000WO2000053161A2 Microparticles for delivery of nucleic acid
09/14/2000WO2000053019A1 Dna vaccination for treatment of autoimmune disease
09/14/2000WO2000037609A3 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/14/2000WO2000037504A3 Human monoclonal antibodies to ctla-4
09/14/2000WO2000037102A3 Improvement of tolerance to a xenograft
09/14/2000WO2000035480A3 Peptides useful in diagnosing and treating hiv-induced acquired immune deficiency disease
09/14/2000WO2000035409A3 Hiv-i fusion inhibition compounds
09/14/2000WO2000031263A3 Gtpase associated proteins
09/14/2000WO2000030668A8 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
09/14/2000WO2000025812A3 Method for preparing solid phase conjugate vaccines
09/14/2000WO2000024913A3 Mn gene and protein
09/14/2000WO1999062941A9 Serpentine transmembrane antigens expressed in human cancers and uses thereof
09/14/2000CA2478736A1 Compositions and methods for the treatment of tumors
09/14/2000CA2478730A1 Compositions and methods for the treatment of tumors
09/14/2000CA2478728A1 Compositions and methods for the treatment of tumors
09/14/2000CA2367334A1 Compositions and methods for the treatment of tumors
09/14/2000CA2367315A1 Apoptosis inducing molecule ii and methods of use
09/14/2000CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases
09/14/2000CA2366147A1 Casb618 polynucleotides and polypeptides and their use
09/14/2000CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000CA2365813A1 Stable recombinant influenza viruses free of helper viruses
09/14/2000CA2365799A1 Cloning and expression of haemophilus somnus transferrin-binding proteins
09/14/2000CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000CA2364507A1 Lipoglycan compositions and methods of treating parasitic infections
09/14/2000CA2364503A1 Compositions and methods for treating cancer and hyperproliferative disorders
09/14/2000CA2364487A1 Treatment of autoimmune disease
09/14/2000CA2364442A1 Intranasal delivery of pneumococcal polysaccharide vaccines
09/14/2000CA2364252A1 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders
09/14/2000CA2363593A1 Nucleic acid respiratory syncytial virus vaccines
09/14/2000CA2362422A1 Polynucleotides and proteins encoded thereby
09/14/2000CA2362370A1 Use of casb616 polypeptides and polynucleotides for cancer treatment
09/14/2000CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization
09/13/2000EP1035209A1 Stable recombinant influenza viruses free of helper viruses
09/13/2000EP1035205A1 Non-spreading pestivirus
09/13/2000EP1035203A1 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants
09/13/2000EP1035137A1 Method for the reductive amination of polysaccharides
09/13/2000EP1035133A2 Fusion proteins comprising carriers that can induce a dual immune response
09/13/2000EP1035132A1 Monoclonal antibody inducing apoptosis
09/13/2000EP1034795A2 Conjugates of lipids and biologically active compounds
09/13/2000EP1034792A1 Intranasal delivery of pneumococcal polysaccharide vaccines
09/13/2000EP1034785A2 Hepatitis C virus diagnostics and vaccines
09/13/2000EP1034295A1 ribA
09/13/2000EP1034289A1 Alphavirus vectors for paramyxovirus vaccines
09/13/2000EP1034277A2 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS)
09/13/2000EP1034276A1 Novel era
09/13/2000EP1034273A1 Histamine and serotonin binding molecules
09/13/2000EP1034264A1 Splice variants for human 5-ht 4? serotonin receptor and their applications, in particular for screening
09/13/2000EP1034252A2 Attenuated strains of mycobacteria
09/13/2000EP1034207A1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES
09/13/2000EP1034187A1 $i(IN VITRO) AND $i(IN VIVO) GROWTH-PROMOTING PROTEINS AND PEPTIDES FOR KIDNEY EPITHELIAL CELLS
09/13/2000EP1034004A1 Recombinant mycoplasma hyopneumoniae vaccine
09/13/2000EP1034003A1 Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
09/13/2000EP1034002A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
09/13/2000EP1034001A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome
09/13/2000EP1034000A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
09/13/2000EP1033996A1 Prevention and treatment of amyloidogenic disease
09/13/2000EP1033995A1 Insect cells or fractions as adjuvant for antigens
09/13/2000EP1033973A1 Encapsulation method
09/13/2000EP0938557B1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
09/13/2000EP0814834B1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same
09/13/2000EP0759941B1 Heterodimer polypeptideimmunogen carrier composition and method for their use
1 ... 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 ... 1823